期刊文献+

RNA干扰技术在肿瘤基因治疗中的研究进展 被引量:2

下载PDF
导出
摘要 RNA干扰(RNA interference,RNAi)是指由双链RNA(double2strand RNA,dsRNA)引发的转录后基因沉默机制(posttranscriptional gene silencing,PTGS),具有序列特异性和高效性,RNAi作为一门新的基因阻断技术,是一种有广阔应用前景的抗肿瘤基因治疗方法,近年来受到人们的广泛关注。本文将RNAi作用机制及其在肿瘤治疗中的研究进展作一综述。
出处 《四川生理科学杂志》 2005年第1期20-23,共4页 Sichuan Journal of Physiological Sciences
  • 相关文献

参考文献28

  • 1[1]Borkhardt, A. Blocking oncogenes in malignant cells by RNA interference: new hope for a highly, specific cancer treatment. Cancer Cells, 2002;2: 167~168. 被引量:1
  • 2[2]Hammond SM, Bemstein E, Beach D, et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in drosophila cells. Nature,2000; 404: 293~ 296. 被引量:1
  • 3[3]Sharp PA.. RNA interference. Genes Dev, 2001;15;485~490. 被引量:1
  • 4[4]Guo S, Kemphues, KJ. Par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell, 1995; 81: 611~620. 被引量:1
  • 5[5]Fire A, Xu S, Montggomery MK, et al. Potent and specificgenetic interference by double-strand RNA in Caenorhabditis elegans. Nature, 1998;391 ;806~811. 被引量:1
  • 6[6]Tuschl T, Elbashir SM, Lendeckel W, et al. RNA interference is mediated by 21-and-22 nucleotide RNAs . Genes Dev, 2001; 15: 188~ 200. 被引量:1
  • 7[7]Gregory J, Hannon. RNA interference. Nature, 2002;418: 244~251. 被引量:1
  • 8[8]Zamore PD, Tuschl T, Sharp PA. et al . RNAi: double-stranded RNA directs the ATP-dependent clavage of Mrna at 21 to 23 nucleotide intervals.Cell, 2000; 101: 25~ 33. 被引量:1
  • 9[9]Patrik J, Paddi.son, Caudy A. et al. Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci USA, 2002; 99: 1443~ 1448. 被引量:1
  • 10[10]Sakamoto, KM. Knocking down humn disease: potential use of RNA interference in research and gene therapy. Pediatric Research, 2004;55 (6):912~913. 被引量:1

同被引文献40

  • 1王雪芹,王滨,张永峰,李丽新,曹贵文,孙业全,王秀春,宁厚发,杜伟.周围型肺腺癌CT征象与VEGF-C、VEGFR-3表达及肿瘤淋巴管密度关系研究[J].中国医学影像技术,2007,23(1):94-97. 被引量:9
  • 2许明月,赵发.VEGF-C与肿瘤淋巴转移[J].现代中医结合杂志,2008,17(16):2578-2581. 被引量:1
  • 3Folkman J. Tumor angiogenesis: theropeutic implication[J]. N Engl J Med, 1971,285(21) : 1182-1186. 被引量:1
  • 4Leung DW, Cachianes G, Kuang WJ, et al. Vascular endotheli- al growth factor is a secreted angiogenic mitogen[J]. Science, 1989,246(4935) : 1306-1309. 被引量:1
  • 5Tischere E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor, multiple protein forms are en- coded through alternative exon splicing[J]. Biol Chem,1991,226 (7) : 11947-11954. 被引量:1
  • 6Gross MJ,Claesson-Welsh L. FGF and VEGF function in angio- genesis: signaling pathways, biological response and therapeutic inhibition[J]. Trends Pharmacol Science, 2001,22 (2): 201-207. 被引量:1
  • 7Chung J, Yoon S, Datta K, et al. Hypoxia-induced vascular endo- thelial growth factor transcription and protection from apoptosis are dependent on alpha6betal integrin in breast carcinoma cells[J]. Cancer Res,2004,64(10):4711-4716. 被引量:1
  • 8张会勇,刘景晶,张笑岩,等.VEGFl65过表达对小鼠乳腺癌及肿瘤周边皮肤血管生成模式的影响研究[J].河北师范大学学报,2010,38(3):115-118. 被引量:1
  • 9Novina CD, Sharp PA. The RNAi revolution [J]. Nature, 2004, 430:161-164. 被引量:1
  • 10Kollermann J, Helpap BF. Expressin of vascular endothelial growth facto r and VEGF receptor Flk-I in begin, premalignant and malig- nant pristate tissue[J]. Am J Clin Pathol, 2001,116 (1) : 115-121. 被引量:1

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部